1. Guest, the 'News in Brief' for the week beginning 14th June 2021 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice
  3. Contribute to feedback on the CDC Evidence Review, for more details click here
    Dismiss Notice

Prevalence of biliary acid malabsorption in patients with chronic diarrhoea of functional characteristics: a prospective study, Flores et al, 2021

Discussion in 'Health News and Research unrelated to ME/CFS' started by Andy, Feb 11, 2021.

  1. Andy

    Andy Committee Member (& Outreach when energy allows)

    Messages:
    13,311
    Likes Received:
    96,211
    Location:
    Hampshire, UK
    Open access, https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-021-01637-4
     
  2. Hutan

    Hutan Moderator Staff Member

    Messages:
    14,127
    Likes Received:
    59,050
    Location:
    New Zealand
    BAM! to ideas of functional illness (Bile Acid Malabsorption, that is.)


    BAD (Bile Acid Diarrhoea)

    Seems like the detailed physiology is fairly well understood:

    Of course, every participant who didn't qualify for the Type 2 BAD diagnosis was left in the functional illness bucket.
    Cos, well, now that we know about bile acid diarrhoea, of course we know all that there is to know about possible causes of diarrhoea...


    And this one is important - doing the test early rather than slapping a functional diagnosis on someone is thought likely to reduce subsequent healthcare related costs, not to mention opening up treatment possibilities:
     
    Simbindi, Snowdrop, Mithriel and 6 others like this.
  3. Hutan

    Hutan Moderator Staff Member

    Messages:
    14,127
    Likes Received:
    59,050
    Location:
    New Zealand
    Here's a 2020 BMJ paper on this:
    https://fg.bmj.com/content/early/2020/09/22/flgastro-2020-101436
    Bile acid diarrhoea: pathophysiology, diagnosis and management

     
  4. Sean

    Sean Senior Member (Voting Rights)

    Messages:
    3,350
    Likes Received:
    28,083
    BAD is a treatable disease, however, the delay in diagnosis causes a significant increase in the diagnostic care cost as well as affecting the quality of life of patients.

    Also true for currently untreatable diseases. Early diagnosis and generic management alone are highly desirable goals, even in the absence of treatments. Just knowing what the problem lets patients maximise what choices they do have.

    Very good to see this message getting into the peer-review literature. Anything that delays diagnosis and treatment/management will increase morbidity and (where applicable) mortality rates.
     

Share This Page